Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

2-Pyrazol-1-yl-thiazole derivatives as novel highly potent antibacterials


The present report describes our efforts to identify new structural classes of compounds having promising antibacterial activity using previously published double-reporter system pDualrep2. This semi-automated high-throughput screening (HTS) platform has been applied to perform a large-scale screen of a diverse small-molecule compound library. We have selected a set of more than 125,000 molecules and evaluated them for their antibacterial activity. On the basis of HTS results, eight compounds containing 2-pyrazol-1-yl-thiazole scaffold exhibited moderate-to-high activity against ΔTolC Escherichia coli. Minimum inhibitory concentration (MIC) values for these molecules were in the range of 0.037–8 μg ml−1. The most active compound 8 demonstrated high antibacterial potency (MIC = 0.037 μg ml−1), that significantly exceed that measured for erythromycin (MIC = 2.5 μg ml−1) and was comparable with the activity of levofloxacin (MIC = 0.016 μg ml−1). Unfortunately, this compound showed only moderate selectivity toward HEK293 eukaryotic cell line. On the contrary, compound 7 was less potent (MIC = 0.8 μg ml−1) but displayed only slight cytotoxicity. Thus, 2-pyrazol-1-yl-thiazoles can be considered as a valuable starting point for subsequent optimization and morphing.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1
Fig. 2


  1. DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ 2016;47:20–33.

    Article  Google Scholar 

  2. Website. Available at: Accessed 7 December 2018.

  3. Singh N, et al. QSAR classification model for antibacterial compounds and its use in virtual screening. J Chem Inf Model. 2012;52:2559–69.

    CAS  Article  Google Scholar 

  4. Gulland A. Antimicrobial resistance is now widespread, warns WHO. Br Med J. 2014;348:g3062–g3062.

    Article  Google Scholar 

  5. Website. Available at: Accessed 7 December 2018.

  6. Kim CT, et al. Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea. Eur Respir J. 2018;51:1702467.

    Article  Google Scholar 

  7. Pontali E, et al. Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review. Eur Respir J. 2018;52:1800934.

    Article  Google Scholar 

  8. Gerasyuto AI, et al. Discovery and optimization of indolyl-containing 4-hydroxy-2-pyridone type II DNA topoisomerase inhibitors active against multidrug resistant gram-negative bacteria. J Med Chem. 2018;61:4456–75.

    CAS  Article  Google Scholar 

  9. Skepper CK, et al. Discovery and optimization of phosphopantetheine adenylyltransferase inhibitors with gram-negative antibacterial activity. J Med Chem. 2018;61:3325–49.

    CAS  Article  Google Scholar 

  10. Chacko S, et al. Expanding benzoxazole-based inosine 5′-monophosphate dehydrogenase (IMPDH) inhibitor structure–activity as potential antituberculosis agents. J Med Chem. 2018;61:4739–56.

    CAS  Article  Google Scholar 

  11. De Schutter JW, Morrison JP, Morrison MJ, Ciulli A, Imperiali B. Targeting bacillosamine biosynthesis in bacterial pathogens: development of inhibitors to a bacterial amino-sugar acetyltransferase from Campylobacter jejuni. J Med Chem. 2017;60:2099–118.

    Article  Google Scholar 

  12. Azzali E, et al. Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides are valuable antitubercular candidates that evade innate efflux machinery. J Med Chem. 2017;60:7108–22.

    CAS  Article  Google Scholar 

  13. Panchaud P, et al. Discovery and optimization of isoquinoline ethyl ureas as antibacterial agents. J Med Chem. 2017;60:3755–75.

    CAS  Article  Google Scholar 

  14. Osterman IA, et al. Sorting out antibiotics’ mechanisms of action: a double fluorescent protein reporter for high throughput screening of ribosome and DNA biosynthesis inhibitors. Antimicrob Agents Chemother. 2016;60:7481–9.

  15. Komarova Andreyanova ES, et al. 2-Guanidino-quinazolines as a novel class of translation inhibitors. Biochimie. 2017;133:45–55.

    CAS  Article  Google Scholar 

  16. ChemDiv - Contract Research Organization. Chemdiv. Available at: Accessed 7 December 2018.

  17. InterBioScreen ltd. Compound Libraries. InterBioScreen ltd. Compound Libraries. Available at: Accessed 7 December 2018.

  18. EnamineStore. Available at: Accessed 7 December 2018.

  19. Osterman IA, et al. Attenuation-based dual-fluorescent-protein reporter for screening translation inhibitors. Antimicrob Agents Chemother. 2012;56:1774–83.

    CAS  Article  Google Scholar 

  20. Schumacher SD, Hannemann F, Teese MG, Bernhardt R, Jose J. Autodisplay of functional CYP106A2 in Escherichia coli. J Biotechnol. 2012;161:104–12.

    CAS  Article  Google Scholar 

  21. Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3:163–75.

    CAS  Article  Google Scholar 

  22. SciFinder - Sign In. Available at: Accessed 7 December 2018.

  23. Website. Available at: Accessed 7 December 2018.

  24. EMBL-EBI. The European Bioinformatics Institute <EMBL-EBI. Available at Accessed 4 December 2018.

  25. Sammon JW. A nonlinear mapping for data structure. Anal IEEE Trans Comput C. 1969;18:401–9.

    Article  Google Scholar 

Download references


The authors would like to kindly acknowledge the Ministry of Education and Science of the Russian Federation, government grant 20.9907.2017/VU (expert opinion, discussion, and paper preparation) and Russian Science Foundation No. 17-74-30012, IBG RAS Ufa (biological evaluation and compound selection).

Author information

Authors and Affiliations


Corresponding author

Correspondence to Anastasia V. Aladinskaya.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ivanenkov, Y.A., Yamidanov, R.S., Osterman, I.A. et al. 2-Pyrazol-1-yl-thiazole derivatives as novel highly potent antibacterials. J Antibiot 72, 827–833 (2019).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


Quick links